NEW YORK--(BUSINESS WIRE)--Regulatory News:
Cellectis (Alternext:ALCLS – Nasdaq: CLLS) today announced that data on its engineered allogeneic CAR T-Cell product candidates, UCARTCS1 and UCART123, will be presented during the 2015 American Society of Hematology Annual Meeting. A poster and an oral presentation will be presented during this event.
Help employers find you! Check out all the jobs and post your resume.
Cellectis (Alternext:ALCLS – Nasdaq: CLLS) today announced that data on its engineered allogeneic CAR T-Cell product candidates, UCARTCS1 and UCART123, will be presented during the 2015 American Society of Hematology Annual Meeting. A poster and an oral presentation will be presented during this event.
Help employers find you! Check out all the jobs and post your resume.
